会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • Variable tint cosmetics
    • 变色调化妆品
    • US20060193800A1
    • 2006-08-31
    • US11340297
    • 2006-01-26
    • John ReinhardtJohn HillMichele WardJ. Brown
    • John ReinhardtJohn HillMichele WardJ. Brown
    • A61K8/02A61K8/97
    • A61Q1/02A61K8/0241A61K8/11A61K8/31A61K8/37A61K8/8111A61K8/922A61K8/97A61K2800/31A61K2800/412A61K2800/43A61Q1/12
    • The disclosed systems and methods for delivery of variable tint pigment materials in cosmetic concealer/foundation products generally include anhydrous carrier particles adapted to carry pigment. The pigmentation carrier particles may be optionally admixed with anhydrous (optionally tinted) base formulation material that is suitably adapted to suspend and/or separate the pigmentation carrier particles. Disclosed features and specifications may be variously controlled, adapted or otherwise modified to realize improved site-specific delivery of pigment in customized concentrations in order to achieve a desired result. Exemplary embodiments of the present invention generally provide anhydrous pigmentation carrier particles that may be mixed with substantially anhydrous topical base formulations that allow a user to deliver a selected concentration of concealer/foundation tint to a specific region of the skin, for example, in order to obscure a blemish.
    • 用于在化妆品遮瑕膏/粉底产品中递送可变色素材料的所公开的系统和方法通常包括适于承载颜料的无水载体颗粒。 色素载体颗粒可以任选地与适当地适于悬浮和/或分离着色载体颗粒的无水(任选着色的)基础制剂材料混合。 公开的特征和规格可以被不同地控制,适应或以其他方式修饰,以实现改变的定制浓度的颜料的位置特异性递送,以获得期望的结果。 本发明的示例性实施方案通常提供可与基本上无水的局部基础制剂混合的无水色素沉淀载体颗粒,其允许使用者将选定浓度的遮瑕膏/基质着色剂递送至皮肤的特定区域,以便 晦涩难懂
    • 20. 发明申请
    • Glaucoma treatment device and method
    • 青光眼治疗装置及方法
    • US20060276739A1
    • 2006-12-07
    • US11311444
    • 2005-12-19
    • J. Brown
    • J. Brown
    • A61M5/00
    • A61F9/00781
    • A device for treating glaucoma in an eye is described. The device includes a body defining a lumen and having first and second ends and external and lumenal surfaces, wherein the body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The device further includes a filter membrane capable of providing outflow resistance to aqueous humor flowing through the lumen. The device further includes a debris filter positioned either at the first end or between the first end and the filter providing outflow resistance. Methods of treating glaucoma wherein the device is implanted in the sclera of an afflicted eye are also described.
    • 描述了用于治疗眼睛中的青光眼的装置。 该装置包括限定内腔并具有第一和第二端以及外部和内腔表面的主体,其中,当所述装置被植入时,所述主体具有足以在所述眼睛的前房和泪膜之间通过所述内腔提供流体连通的长度 巩膜 所述装置还包括能够提供流过所述内腔的房水的流出阻力的过滤膜。 该装置还包括位于第一端处或位于第一端和过滤器之间的碎屑过滤器,提供流出阻力。 还描述了将装置植入患有眼睛的巩膜中的治疗青光眼的方法。